seed
Stage
1
Investors
About
Biossil is an AI-native biopharma company based in Toronto developing and advancing late-stage clinical programs for personalized drug trials targeting life-threatening diseases including Sickle Cell Disease, Glioblastoma, Alzheimer's Disease, and others.
Explore Biossil's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.